Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indo US Bio-Tech's Enterprise Value for the quarter that ended in Jun. 2026 was ₹ Mil.
Indo US Bio-Tech's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was ₹147 Mil. Indo US Bio-Tech's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was %.
The historical rank and industry rank for Indo US Bio-Tech's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
NSE:INDOUS'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.64 Med: 3.37 Max: 9.42
Current: 7.94
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Indo US Bio-Tech was 9.42%. The lowest was 1.64%. And the median was 3.37%.
NSE:INDOUS's Earnings Yield (Joel Greenblatt) % is ranked better than 59.32% of 263
companies
in the Agriculture industry
Industry Median: 6
vs NSE:INDOUS: 7.94
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Indo US Bio-Tech's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was %. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Indo US Bio-Tech (NSE:INDOUS) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Indo US Bio-Tech Earnings Yield (Joel Greenblatt) % Related Terms
Indo US Bio-Tech Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indo US Bio-Tech Earnings Yield (Joel Greenblatt) % Chart
For the Agricultural Inputs subindustry, Indo US Bio-Tech's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech Earnings Yield (Joel Greenblatt) % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's Earnings Yield (Joel Greenblatt) % falls into.
Indo US Bio-Tech Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Indo US Bio-Techs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Mar. 2026 is calculated as
Indo US Bio-Tech's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹147 Mil.
What does a Earnings Yield (Joel Greenblatt) % of % mean?
Indo US Bio-Tech (NSE:INDOUS) has a Earnings Yield (Joel Greenblatt) % of % as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Indo US Bio-Tech and its competitors. Over the past decade, Indo US Bio-Tech's Earnings Yield (Joel Greenblatt) % has ranged from 1.64 to 9.42. According to the industry distribution chart, Indo US Bio-Tech ranks #107 out of 263 companies in the Agriculture industry, placing it in the top 40.7%.
Is Indo US Bio-Tech's Earnings Yield (Joel Greenblatt) % too high?
Indo US Bio-Tech's current Earnings Yield (Joel Greenblatt) % is %. Over the past 10 years, this metric has ranged from a low of 1.64 to a high of 9.42. Based on the distribution chart, Indo US Bio-Tech ranks #107 out of 263 companies in the Agriculture industry, which is above the industry midpoint. Overall, Indo US Bio-Tech has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's Earnings Yield (Joel Greenblatt) % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #107 out of 263 companies for Earnings Yield (Joel Greenblatt) %. This puts Indo US Bio-Tech in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 6.00. Historically, Indo US Bio-Tech's own Earnings Yield (Joel Greenblatt) % has ranged from 1.64 to 9.42 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for an Agriculture company?
The median Earnings Yield (Joel Greenblatt) % among Agriculture companies is 6.00, based on 263 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median Earnings Yield (Joel Greenblatt) % is 6.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current Earnings Yield (Joel Greenblatt) % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹299.87, compared to a current price of ₹78.00 — trading 74% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is %. Indo US Bio-Tech's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current Earnings Yield (Joel Greenblatt) % is % as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹78.00 is trading 74% below its estimated GF Value™ of ₹299.87.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
Earnings Yield (Joel Greenblatt) %: %
GF Value™: ₹299.87 vs. price of ₹78.00 (74% below fair value)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
66GF Score
Get the complete analysis for NSE:INDOUS
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
